SG

Swati Goyal

Active Director Director DIN 10744098
DIN 10744098 First appointment Aug 2024 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2024
Shareholding value •••• Premium profile

About Swati Goyal

Data last updated:

Swati Goyal is a Director at Imperial Biotech Private Limited (since 2024). The company operates in Healthcare. Imperial Biotech Private Limited reported revenue of ₹16.04 Cr (FY 2025).

DIN 10744098
Primary Designation Director
Industry Healthcare
First Appointment 29 Aug 2024
Oldest Company Age 6 yrs
Largest company Imperial Biotech Private Limited · ₹16.04 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Imperial Biotech Private Limited U51397UP2020PTC242636
Director29 Aug 20242020₹16.04 Cr (FY 2025)Active

Board colleagues of Swati Goyal

NameDINCompanyDesignation
Darshitam Goyal07290401Imperial Biotech Private LimitedDirector

Directorship timeline

Open interactive timeline →
Imperial Biotech Private Limited
Premium access

Shareholding and investment profile for Swati Goyal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Swati Goyal

Swati Goyal currently holds 1 directorship: Imperial Biotech Private Limited (Director, since 29 Aug 2024, revenue ₹16.04 Cr (FY 2025)).

Swati Goyal was first appointed on 29 Aug 2024 as Director at Imperial Biotech Private Limited.

The current boards of Swati Goyal's companies include Darshitam Goyal (Imperial Biotech Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available